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Background: The growing use of imaging procedures in medicine has raised concerns about exposure to low-
dose ionising radiation (LDIR). While the disastrous effects of high dose ionising radiation (HDIR) is well
documented, the detrimental effects of LDIR is not well understood and has been a topic of much debate. Since
little is known about the effects of LDIR, various kinds of wet-lab and computational analyses are required to
advance knowledge in this domain. In this paper we carry out an “upside-down pyramid” form of systems biology
analysis of microarray data. We characterised the global genomic response following 10 cGy (low dose) and
100 cGy (high dose) doses of X-ray ionising radiation at four time points by analysing the topology of gene
coexpression networks. This study includes a rich experimental design and state-of-the-art computational systems
biology methods of analysis to study the differences in the transcriptional response of skin cells exposed to low
and high doses of radiation.
Results: Using this method we found important genes that have been linked to immune response, cell survival
and apoptosis. Furthermore, we also were able to identify genes such as BRCA1, ABCA1, TNFRSF1B, MLLT11 that
have been associated with various types of cancers. We were also able to detect many genes known to be
associated with various medical conditions.
Conclusions: Our method of applying network topological differences can aid in identifying the differences among
similar (eg: radiation effect) yet very different biological conditions (eg: different dose and time) to generate
testable hypotheses. This is the first study where a network level analysis was performed across two different
radiation doses at various time points, thereby illustrating changes in the cellular response over time.
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Humans are exposed to ionising radiation from natural
and medical (either therapeutic or occupational) sources.
While occupational related exposure involves low doses
of radiation (< 0.5 Gy), therapeutic doses of radiation
can be moderate to high (> 1 Gy). Medical procedures,
such as diagnostic X-rays, nuclear medicine, and radi-
ation therapy are the most significant source of man-
made radiation exposure to the general population. The
growing use of imaging procedures has raised concerns
about exposure to low-dose ionising radiation (LDIR).* Correspondence: dmrocke@ucdavis.edu
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reproduction in any medium, provided the orIonising radiation can induce various forms of DNA
damage, including the possibility of increasing the inci-
dence of chromosomal aberrations. While the disastrous
effects of high dose ionising radiation (HDIR) is well
known and accepted, the detrimental effects of low dose
radiation is not well understood and has been a topic of
much debate. With the advancement of high-throughput
genomic technologies, global gene (mRNA) expression
profiling is one of the latest approaches used to obtain
information about the global cellular response to
radiation.
Since skin is the first organ exposed to radiation, it is im-
portant to elucidate the cellular and molecular responses of
skin cells to LDIR. However, due to ethical complications
in using human skin cells for experimentation with. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mand. Therefore, in this study we use EpiDermFT, which is
a three-dimensional full thickness skin model that is com-
posed of normal human epidermal keratinocytes (NHEK)
and normal human dermal fibroblasts (NHDF). It is a reli-
able model since in recent years other fields of investigation
such as carcinogenesis [1], [2] and wound healing [3] have
been using this model in their studies. This reconstructed
skin tissue is becoming an attractive in vitro model for
studying the effect of radiation [4-6].
Since microarray expression data include lots of false
positives, methods that allow for further gene extraction
from the set of differentially expressed genes are
required. As these methods are applied in a step-wise
fashion the criteria also get more stringent with each
step resulting in a fewer number of false positives (see
Figure 1). To this end we apply the network topological
analysis. Furthermore, it also aids in identifying the few
genes that may be the key players in the condition.
In this study we characterised the global genomic re-
sponse following 10 cGy (low dose radiation) and
100 cGy (high dose radiation) doses of X-ray ionising ra-
diation in a tissue model by analysing the topology of
gene co-expression networks. Due to massive amounts
of data that get churned out via high throughput tech-
nologies such as microarrays, methods to sieve through
such large amounts of data in order to identify groups of
genes of interest are essential. This is what we term an
üpside-down pyramid” kind of analysis. Since it is well
known that not a single gene, but rather groups of genes
with small changes in their expression result in a con-
certed global response, a systems biology approach will
provide a global view of the underlying response to aFigure 1 Upside down pyramid approach of identifying key
genes in a condition. As microarray data have lots of false positives
(noisy data), it is crucial that layers of gene filtering approaches be
applied in order to obtain a set of few genes that may be
contributing to the condition or genes that may be signatures of
the condition (for clinical diagnostic purposes).certain condition or treatment. In this study, we use two
graph theory methods - differential neighbourhood ana-
lysis, specifically topological/neighbourhood overlap and
the difference in connectivity of genes in the coexpres-
sion networks of 10 cGy and 100 cGy - to identify inter-
esting genes and the enriched biological processes in
irradiated skin cells. The topological overlap method has
been previously used to investigate the severity of
Alzheimer’s disease in multiple brain regions [7,8].
If the neighbourhood of a gene in coexpression net-
works is representative of the ‘biological activity’ of the
gene under a certain condition, then genes with high
topological overlap (high overlap of their neighbours)
between two dose-specific networks, may not differ
greatly in their response to the two irradiation doses.
However, genes with low topological overlap probably
have roles/activities that are dose-specific. Many studies
investigate only the genes that are unique to a condition,
not common between conditions, in order to analyse
how different the conditions are. However, we hypothe-
sise that even the genes that are common between con-
ditions (physiological, treatment or time) can contribute
to the differences between conditions either by invoking
different biological pathways or by invoking the same
biological pathways but to varying degrees. In this study,
we aimed to identify the differences between low dose
and high dose ionising radiation contributed to by the
genes common to both conditions by studying the gene
coexpression network topology.
Studies have used the topological overlap measure for
identifying metabolites that are in the same functional
class [9], or for module detection, i.e. clustering of genes
[10]. Other network measures have been used for other
objectives as in [11-14]. While topological measures
have been developed for the purposes of examining rela-
tionships among genes within the same network, our
topological measure was developed to compare two dif-
ferent networks and use it to study the behaviour of a
particular gene in separate gene coexpression networks,
which represent different conditions, (i.e. different ionis-
ing radiation doses). In this manner, the measure was
used as a means of computing gene coexpression net-
work differences and then associating these differences
with dose-related responses.
Methods
Tissue irradiation and processing
Microarray expression data was obtained from a global
gene expression study aimed at assessing the genomic
response to radiation conducted by Yunis et al. [15]. The
details of the experimental protocol are presented there,
but briefly, the effect of low versus high dose X-ray radi-
ation on the gene expression was evaluated in a three-
dimensional skin tissue model (EpiDermFT-400; MatTek
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structed skin tissue, which is composed of keratino-
cytes that make up the epidermal layer, and
fibroblasts that make up the dermal layer of the skin.
Tissues were irradiated with 0, 10, and 100 cGy X-ray
(i.e. 0, 0.1 and 1 Gy, respectively) radiation at a dose
rate of 50 cGy/min using a clinical irradiator at the
department of Radiation Oncology of the UC Davis
Medical Center. Skin plugs were harvested at 0, 3, 8,
and 24 h post irradiation. The 0 time point is about
5 min after exposure. There were 2 replicates at each
time point (4 time points) and dose (3 doses) result-
ing in a total of 24 samples in the dataset. The integ-
rity of the extracted RNA was verified using the 2100
Bioanalyzer (Agilent, Santa Clara, CA), and 300 ng
total RNA was reverse transcribed, amplified and la-
beled. The resulting cRNA was hybridised to Illumina
HumanRef-8 Expression Beadchips [HumanRef-
8_V3_0_R2_11282963_A] and interrogated at the UC
Davis Expression Analysis Core. The HumanRef-8
Expression Beadchip contains approximately 24 K
well-annotated probes. All the data has been depos-
ited in PubMed (GEO accession record GSE29344).Microarray data processing
Data preprocessing included the following five steps:
generation of probe intensities data, data quality con-
trol, data transformation and normalisation, gene fil-
tering and statistical analysis. The raw data,
containing approximate 24 K probes and associated
gene information, was processed by BeadStudio 3.4.0
along with annotation file HumanRef-8-V3-0-R2.
Background subtraction of the intensities was per-
formed in order to remove signals resulting from non-
specific hybridisation. The assessment of data quality
plays a crucial role in data analysis as it basically
affects downstream analysis. For quality control, we
used the Bioconductor packages lumi 1.2.0 [16] and
arrayQualityMetrics 2.2.3 [17] to identify potential
outlier samples. In our data, there were no outlier
samples.
Application of standard statistical analysis techni-
ques assumes that the data is normally distributed and
has equal variance. When data violate these assump-
tions, appropriate data transformation is required. To
satisfy the constant variance assumption, we trans-
formed the probe intensities data (y) with the transeS
function from Bioconductor package LMGene. This
package was developed from our lab and is designed
for analysis of gene expression microarray data (see
LMGene package in R). It applies g-log transform
(generalised log transformation) for data transform-
ation to stabilise variance [18,19].The g-log transformation of y is defined as





transeS is a function of subtracting a parameter α prior
to the g-log transformation
g yð Þ ¼ ln y αð Þ þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
y αð Þ2 þ λ
q 
ð2Þ
Two parameters λ and α can be estimated using tran-
est function from LMGene package. tranest is a function
that uses maximum likelihood method to estimate the
two parameters for the g-log transformation. LMGene
was developed by our group and is similar to Limma.
Limma estimates the mean square error (MSE) for each
gene using a hierarchical empirical Bayes model for the
collection of MSEs. LMGene provides the user with the
choice of using the gene-specific MSE or the posterior
MSE. The latter can be more powerful when the degrees
of freedom (df ) in the denominator of the F test is small,
but it does entail an additional collection of assump-
tions. Since in this data set we have 12 df for the MSE in
each gene, we chose to use the gene-specific MSE.
The plot of rank mean versus standard deviation for
the raw data with background subtraction shows a
massive range of the standard deviation from 5.307 to
22880. As seen in Figure 2, there was enormous vari-
ation of standard deviation. After g-log transformation
and quantile normalisation, the standard deviation of the
transformed and normalised data has become more
stable and the range significantly reduced (Figure 3).
The standard deviation varied from 0.00559 to 1.081,
which was a dramatic decrease compared to that of the
raw data with background subtraction. Such preproces-
sing of the data resulted in a remarkable improvement
in stabilising variance.
Noisy gene filtering prior to statistical analysis is per-
formed to improve the power of detecting differentially
expressed genes [20,21]. We checked the detection p-
values of probes in the probe-based profile generated by
BeadStudio. If a probe had a detection p-value> 0.05
across all that samples, then the intensities of the probe
were considered unreliable and such probes were
excluded from further analysis. After filtering out all
probes with unreliable intensities, we were left with ap-
proximately 16 K probes that had a detection p-value
< 0.05 in at least 1 sample. Then analysis of variance
(ANOVA) model was used to detect statistically signifi-
cant differentially expressed (DE) genes. Benjamini and
Hochberg method was used to calculate false discovery
rate (FDR) of the DE genes. For the identification of DE
genes in this study, we compared gene expression pro-
files between 0 cGy (control) and 10 cGy (low dose
Figure 2 Data preprocessing - no normalisation. The plot of ranked mean of probe intensities versus their standard deviation for the raw data
with background subtraction. The standard deviation shows a huge variation when compared to the mean intensities. The solid red line is a
lowess smooth line of the probe intensities.
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radiation) at each time point (0 h (control), 3 h, 8 h and
24 h).
Coexpression networks creation and Neighbourhood
analysis
For the sake of brevity, the details of the neighbourhood
analysis method are only briefly described here. Please
refer to [7] for a more detailed explanation. Gene coex-
pression networks were built by connecting genes whose
pairwise expression similarity using the Pearson correl-
ation coefficient (PCC) was at or above a threshold t.
For two genes to be considered as coexpressed, their ex-
pression profiles need to satisfy at least one of the fol-
lowing conditions: (1) their correlation coefficient is
higher than 0.3, and one gene is ranked as the top 3
most correlated gene of the other; (2) the correlation co-
efficient between them is higher than a user defined
Pearson correlation coefficient threshold t (t= 0.9 in all
the networks constructed here) and one gene is within
the top 50 most correlated gene of the other [22]. This
network method was invented by Ruan and Zhang and
is described in detail in [22]. The main reason for choos-
ing a small PCC cut-off of 0.3 is that as the PCC increases
the number of nodes with no links also increases (SeeFigure 1 in [22]). We want a fully connected network with
no isolated nodes. Also, we chose to connect the nodes
with PCC of 0.3 only to 3 nodes since the median number
of links is very high for nodes with a low PCC and that
would result in too many unnecessary links with low PCC
(See Figure 1 in [22]). According to the first condition, if 3
genes are correlated to say, gene A with correlation coeffi-
cients equal to 0.3, 0.32, and 0.4 then they get linked to
gene A. On the other hand, if the 3 genes are correlated to
gene A with correlation coefficients equal to 0.3, 0.28 and
0.29, then only 1 gene would get linked to gene A. How-
ever this scenario rarely, if at all, occurs in gene expression
data with a correlation coefficient threshold of 0.3, hence
the minimum connectivity in the networks in this paper is
3. We chose a high PCC of 0.9 in the 2nd criterion in
order to have genes connected to others resulting in links
between genes that have a higher possibility that they are
coexpressed.
This approach resulted in a sparse, fully connected and
undirected coexpression network. Minimally complex,
sparse gene networks have been shown to be more robust
to perturbations and may be a constraint in shaping the
evolution of gene network complexity in organisms [23].
This network method has had other successful applica-
tions [7,8,24,25].
Figure 3 Data preprocessing - with normalisation. The plot of ranked mean of probe intensities versus their standard deviation for the g-log
transformed and quantile normalised data. The standard deviation shows relatively constant variation when compared to the mean intensities.
The solid red line is a lowess smooth line of the probe intensities.
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an irradiation dose at a specific time, using the differen-
tially expressed (DE) genes that were common to both
doses, i.e. the intersection set. Additionally, gene coex-
pression networks were also created using the all the DE
genes obtained by comparing irradiated and non-
radiated controls in order to compare the connectivity
of the common DE genes in the dose-specific networks.
For a clear understanding of the networks construction
refer to Table 1 and Figure 4. The coexpression network
obtained from CoExp is a binary adjacency matrix with
0 referring to no link between two genes and 1 corre-
sponding to a link between the genes. Neighbourhood
analysis was performed via computing the overlap of the
neighbourhoods of genes in two coexpression networks.
Let two coexpression networks built from the intersec-
tion of DE genes be referred to as network1 and net-
work2 corresponding to dose 1 and dose 2 at time T1,
respectively. Since network1 and network2 were built
using the intersection genes between doses 1 and 2, the
nodes in both the networks are the same, although the
connections among them are different. Let each node/gene
in the network be denoted as genei where i=1,2,. . .,m and
m is the total number of nodes in the network. Topological
overlap between network1 and network2 refers to theoverlap of the genes connected to genei in network1 and
network2, i.e. overlap of the neighbourhoods of genei. Let
the genes connected to a genei in network1 be referred to as
X and those in network2 be referred to as Y. The connectiv-
ity or degree of genei in network1 is d1i and that in
network2 is d1i. The topological overlap (TO) for genei be-
tween network1 and network2 is given by
TOgenei ¼
X \ Yj j
max d1i; d2ið Þ ð3Þ
The value of TO of any gene ranges from 0 to 1, with
1 indicating maximum overlap of its neighbourhoods in
both networks. In gene coexpression networks, the max-
imum value of TO will, more often than not, be less
than 1. Further details of this method are presented in
[7].
In this analysis, genes with a topological overlap of
≤ 0.1 between two networks were selected for further
analyses since this resulted in less than 10% of the genes
in the network being selected under this criteria. Genes
with other values of topological overlap, if properly justi-
fied, can also be considered. Comparisons against 1000
random networks (random additions or deletion of links
to the original network while keeping the degree of the
Figure 4 Gene co-expression network construction. Gene co-expression networks built from sets of differentially expressed genes. For each
time point, 4 co-expression networks were built using the differentially expressed (DE) genes and the samples from that time and dose
comparison. For instance, at time 0 h, the co-expression networkA was built from the expression of the 810 DE genes in the samples exposed to
10 cGy and non-exposed samples (Dose 0 cGy). Similarly, the co-expression networkB was constructed using the 525 DE genes from samples
exposed to 100 cGy and non-exposed samples. Co-expression networks netAB1 and netAB2 were built using the set of DE genes common to
both dose0-10 and dose0-100 comparisons but with different samples.
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were made to assess the significance of the genes with
TO=0.1.
Biological analysis and interpretation of genes of interest
was performed by identifying significant biological pro-
cesses or pathways. Statistically significant biological path-
ways were identified using the well annotated GeneGo
MetaCoreTM database [26], which is a commercial tool.
MetaCoreTM is based on a proprietary manually curated
database of human protein-protein, protein-DNA and
protein compound interactions, metabolic and signalling
pathways and the effects of bioactive molecules in gene
expression [26]. We upload a set of genes into GeneGo
MetaCore module and GeneGo checks to find which
pathways are significant with a FDR =0.05 (default set-
ting). It compares the user’s uploaded set of genes withthe set of genes/proteins stored in their Pathways Data-
base. Significance (p-values) in GeneGo of a biological
pathway is evaluated based on the size of the intersection
between user’s dataset and set of genes/proteins corre-
sponding to a network module/pathway in question.
Thorough details of the significance calculation is pro-
vided in [27,28].Results and discussion
Global gene expression profiles
Table 2 shows the number of differentially expressed
(DE) genes for each dose comparison with control dose
0 cGy, at a specific time point as well as the common
DE genes between dose comparisons (DE genes provided
in Additional file 1).
Table 1 Gene co-expression networks nomenclature and number of differentially expressed (DE) genes (nodes) used to
construct them
Networks built with DE genes from dose comparisons with control at time
Dose Comparison at Time No.DE genes Network name (samples used to build net)
Dose 0–10 at T0 810 networkA (samples with dose 0 and 10 cGy at T0)
Dose 0–100 at T0 525 networkB (samples with dose 0 and 100 cGy at T0)
Dose 0–10 at T3 1008 networkC (samples with dose 0 and 10 cGy at T3)
Dose 0–100 at T3 1000 networkD (samples with dose 0 and 100 cGy at T3)
Dose 0–10 at T8 203 networkE (samples with dose 0 and 10 cGy at T8)
Dose 0–100 at T8 972 networkF (samples with dose 0 and 100 cGy at T8)
Dose 0–10 at T24 702 networkG (samples with dose 0 and 10 cGy at T24)
Dose 0–100 at T24 953 networkH (samples with dose 0 and 100 cGy at T24)
Networks built with common DE genes from two dose comparisons with control at time
Dose Comparison at Time No.common DE genes Network name (samples used to build net)
Dose 0–10 at T0 199 netAB1 (samples with dose 0 and 10 cGy at T0)
Dose 0–100 at T0 netAB2 (samples with dose 0 and 100 cGy at T0)
Dose 0–10 at T3 503 netCD1 (samples with dose 0 and 10 cGy at T3)
Dose 0–100 at T3 netCD2 (samples with dose 0 and 100 cGy at T3)
Dose 0–10 at T8 86 netEF1 (samples with dose 0 and 10 cGy at T8)
Dose 0–100 at T8 netEF2 (samples with dose 0 and 100 cGy at T8)
Dose 0–10 at T24 482 netGH1 (samples with dose 0 and 10 cGy at T24)
Dose 0–100 at T24 netGH2 (samples with dose 0 and 100 cGy at T24)
In networkA (number of nodes = 810) inter-gene correlation was computed for samples exposed to dose 0 and 10 cGy at time 0. In networkB (number of
nodes = 525) inter-gene correlation was computed for samples exposed to dose 0 and 100 cGy at time 0. In networkC inter-gene correlation was computed for
samples exposed to dose 0 and 10 cGy at time 3. In networkD inter-gene correlation was computed for samples exposed to dose 0 and 100 cGy at time 3. Same
protocol for networks networkE,networkF, networkG and networkH. In netAB1 (number of nodes = 199) inter-gene correlation was computed for samples exposed
to dose 0 and 10 cGy at time 0. Same protocol for networks netAB2, netCD1, netCD2, netEF1, netEF2, netGH1 and netGH2. The main difference between networks
in the top half and the bottom half of the table is the nodes/DE genes used to construct them
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time. We observed that while dose 100 cGy perturbed
fewer genes than dose 10 cGy initially, over time the
number of perturbed genes increased and remained al-
most the same. Meanwhile, the response to dose 10 cGy










Dose 0–10 T0 810 199 17.5
Dose 0–100 525
Dose 0–10 T3 1008 503 33.4
Dose 0–100 1000
Dose 0–10 T8 203 86 7.9
Dose 0–100 972
Dose 0–10 T24 702 482 41.1
Dose 0–100 953
Percentage of common DE genes is given by
number of common DE genes
Dose 1 comparison DE genes þ Dose 2 comparison DE genes  number of common DE genesð Þ  100with time. Furthermore, the difference in the number of
perturbed genes due to the two doses was the largest at
time 0 and 8 h. Top GO processes of the DE genes at
each dose and time comparison is shown in Figure 5.
An interesting observation that can be noted from
Table 2 is that the percentage of common DE genes in
each of the 4 scenarios were quite large. Furthermore,
the percentage of common DE genes within each set of
DE genes is also quite large. For instance, the set of 482
common genes at T24 is 68.7% of the set of 702 DE
genes obtained from comparing dose 0 and dose 10 cGy
at T24. This indicates that there are many similar
responses to the low dose and high dose radiation.
When analysis of the biological processes of the unique
genes (all DE genes minus the common DE genes for
each comparison) was carried out for each dose com-
parison at each time point, a wide range of cellular pro-
cesses were present (data not shown). It was not
possible to highlight the differences in response between
the high and low dose based on the unique genes alone.
Since microarray expression data include lots of false
positives, methods that allow for further gene extraction
from the set of differentially expressed genes are
Figure 5 Top few statistically significant (FDR=0.05) GO processes of the DE genes of each dose comparison at each time point. Left
side of the figure shows the significant processes and the right side shows the comparison performed. No statistical significant processes was
identified for the dose0-100 time 0 comparison..
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fashion the criteria also get more stringent with each
step resulting in a fewer number of false positives. To
this end we apply the network topological analysis.
Figure 4 illustrates the way in which different dose
specific coexpression networks were built at each time
point and the genes/nodes used in their creation. Table 1
shows the nomenclature of the gene coexpression net-
works and the number of DE genes (nodes) used to con-
struct them.When we analysed the common DE genes between the
dose 0–10 cGy and dose 0–100 cGy comparisons at time
0 h (5 min post radiation), we found a wide range of bio-
logical processes perturbed, but with no specific processes
dominating. We attributed this phenomenon to the fact
that the system may have been going through initial shock
rather than responding to the specific irradiation doses.
Furthermore, if it was going through shock and respond-
ing to radiation dose, it is difficult to differentiate the two
effects, i.e. data has low power to distinguish these effects.
Figure 6 Analysis strategy. Analysis strategy for comparing dose-specific gene co-expression networks for topological overlap and connectivity
differences. Each network refers to a particular dose-specific network at a particular time point. Analysis I refers to comparing topological overlap
and connectivity differences between networks built with common DE genes. In Analysis I, netAB1 is compared with netAB2, netCD1 with net
CD2, netEF1 with netEF2 and netGH1 with netGH2. Analysis II refers to comparing connectivity differences only. In this step, networkA is
compared to networkB (In order to keep the picture clear, we did not put an analysis arrow between networkA and networkB across the picture)
to identify genes with high connectivity difference and the selected genes are also investigated in the comparison between netAB1 and netAB2.
This kind of analysis is carried out for all the networks in a similar fashion.
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3, 8 and 24 h when the expression patterns of the genes
were more likely responding to the radiation dose. How-
ever, it is interesting to note that dose 10 cGy perturbed a
greater number of genes compared to dose 100 cGy at
time 0 h, an observation that needs further investigation.
Similar effect was also observed in other LDIR studies
[29,30]. One possible explanation for this could be that
cells are quicker to respond to the low dose radiation as
they are not as ßtunned” as the cells exposed to the high
dose. Once recovered from the exposure, the high dose
irradiated cells have high numbers of perturbed genes.
Genes with low topological overlap between irradiation
dose networks
We computed the topological overlap (TO) (see Methods)
of each gene between two dose-specific coexpressionnetworks built with the set of common DE genes - for in-
stance compared netCD1 with netCD2; netEF1 with
netEF2; and netGH1 with netGH2 (see Figure 6 - Analysis
I).
The motivation behind the low topological overlap
idea is that genes with low topological overlap (low TO
genes) may be performing different activities/roles or are
a part of different biological processes in the two net-
works. Therefore, we investigated the neighbours of the
low TO genes. ‘Neighbours’ of the low TO genes refer
to the genes directly connected to the gene that has a
low topological overlap between two networks. We iden-
tified the enriched biological processes of the neighbours
of some of these low TO genes to understand what pro-
cesses were changing across doses.
We investigated genes with a TO value ≤ 0.1. These
genes were considered to have ‘low TO’ between two
Figure 7 Low topological overlap genes. The GO processes of the 31 genes with low topological overlap (TO≤ 0.1) between networks netCD1
and netCD2 and 14 genes between networks netGH1 and netGH2..
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between nets netCD1 and netCD2 and 14 (2.3%) genes
with a TO ≤ 0.1 between nets netGH1 and netGH2 (Fig-
ure 7). As can be seen, choosing a threshold of 0.1
resulted in less than 10% of the genes in the network
being selected using this criteria. Since the conditions
are similar (both are exposure to radiation; 50% of the
samples (dose 0) are the same across two networks (see
Table 1); and high overlap of the common DE genes -
Table 2, 4th column) the two networks cannot be very
different. However, there would be a small number of
genes contributing to the difference between the net-
works since the conditions are not identical. Since the
system used in this study is a skin model made of kerati-
nocytes and fibroblasts and, although it is a good model
to study human skin, it is not the complete skin model
(with nerves, blood vessels, glands, etc.) that exists in
real human skin. Therefore, there is bound to be more
similarities between the different networks than differ-
ences. The statistical significance (p value) of these genes
with TO=0.1 was p< 0.05. There were no genes with
TO ≤ 0.1 with a statistical significance of p< 0.05between networks netEF1 and netEF2. This was due to
the small size of the network.
The biological processes of the 31 genes which had a
low TO between netCD1 and netCD2 were analysed
(see Additional file 2). Endothelial cell contacts by junc-
tional mechanisms (p =2.5e-2), regulation of translation
initiation (p =2.6e-2), granzyme A signalling (p =2.9e-2),
granzyme B signalling (p =3.1e-2), etc. emerged as sig-
nificant processes. Granzymes are serine proteases that
are released by cytoplasmic granules within cytotoxic T
cells and natural killer cells and induce apoptosis [31].
Granzyme B is responsible for the rapid induction of
caspase-dependent apoptosis [31]. Granzyme-A-induced
cell death is mainly characterised by the generation of
single-stranded DNA nicks [31]. The significant bio-
logical processes of the 14 genes, which had low TO be-
tween netGH1 and netGH2, included glutathione
metabolism (p =1.7e-3), anti-apoptotic TNFs/NF-KB/
IAP pathway (p =2.6e-2), cell cycle - transition and ter-
mination of DNA replication (p =2.7e-2), keratan
sulphate metabolism, (p =3.4e-2). Studies have shown
altered glutathione levels in cells exposed to ionising
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olism as one of the highly affected processes at 24 h
across the two doses is interesting and should be further
investigated.
We also checked to see which biological pathways
were differentially affected between the set of 31 genes
and 14 genes, i.e. biological pathways that were differen-
tially affected at time 3 h and 24 h. Glutathione metabol-
ism emerged as the significant pathway (FDR= 0.05).
Glutathione has been known to play an important role
in antioxidant defense, nutrient metabolism, and regula-
tion of cellular events [34]. It’s metabolism has been
associated with both protective and pathogenic roles in
cancer [35].
Of the 31 low TO genes between netCD1 and netCD2,
13 genes were downregulated at both doses and 17 genes
were upregulated at both doses. However, 1 gene - Sorbin
and SH3 domain-containing protein 1 (SORBS1) was
downregulated at dose 10 cGy and upregulated at dose
100 cGy. Of the 14 low TO genes between netGH1 and
netGH2, 9 were downregulated at both doses and 5 were
upregulated at both doses. Of interest was tumor necrosis
factor receptor superfamily, member 1B (TNFRSF1B)
which was upregulated. Studies have suggested a role of
TNFRSF1B in protecting neurons from apoptosis by
stimulating antioxidative pathways [36]. The TNF super-
family has been a rich source for drug targets in inflam-
matory and autoimmune diseases as well as cancer [36].
We imported the list of 31 and 14 genes into DAVID
(http://david.abcc.ncifcrf.gov) to identify the association
of these genes with any known diseases/conditions. It
was interesting to note that the list of 31 genes is linked
to immune, cardiovascular, developmental, cancer and
metabolic conditions (see Additional file 3). The set of
14 genes is linked to cancer, ageing, cardiovascular, im-
mune, and metabolic among other conditions (see
Additional file 4). This shows that these genes are im-
portant and play a role in radiation response.
Connectivity difference between irradiation dose
networks built with common DE genes
We also investigated the difference in the number of
network connections (edges or links in the co-
expression network) of the common DE genes between
the two networks built for each dose comparison at a
specific time (see Figure 6 - Analysis I). Our hypothesis
is that genes with a high connectivity difference are
‘more active’ or ‘over expressed’ at a specific dose and
time, thereby activating certain biological processes. We
defined a ‘high’ difference in connectivity if a gene had a
difference of ≥ 10 connections between dose 0–10 cGy
and dose 0–100 cGy networks at a specific time point.
At 3 h there were 114 genes that had a high difference in
connectivity between dose 0–10 cGy and dose 0–100 cGynetworks. There were 55 genes with a higher connectivity
in dose 0-10 cGy network and 59 genes with a higher con-
nectivity in dose 0–100 cGy network (See Additional file
5). The significant biological processes of the 55 and 59
genes are shown in Figure 8. It can be seen that while im-
mune response was the major response in the cells
exposed to dose 10 cGy, cell cycle processes were dominat-
ing at dose 100 cGy.
At 8 h there were 38 genes with a high connectivity
difference between dose 0–10 cGy and dose 0–100 cGy
networks (See Additional file 6). The significant bio-
logical processes of the genes with higher connectivity in
the individual networks is shown in Figure 9. While me-
tabolism related processes were prominent in cells
exposed to dose 10 cGy and DNA damage induced pro-
cesses were active in cells exposed to 100 cGy.
At 24 h there were 122 genes with a high connectivity
difference between dose 0–10 cGy and dose 0–100 cGy
networks and their biological processes are shown in
Figure 10 (See Additional file 7). It was interesting to
note that at 24 h, processes involved with Wnt signalling
was beginning to overshadow other processes in cells
exposed to 10 cGy radiation while cell cycle processes
prevailed in cells exposed to 100 cGy radiation. The
Wnt signalling pathway has been associated with car-
cinogenesis and development [37-39].
Figure 11 shows the change over time and dose in
terms of different biological processes being dominant.
This clear highlighting of the different sets of processes
active at the different doses is due to the application of
topological methods (see Figures 5, 8, 9, 10). Our results
indicate that at low dose the cells are involved in adap-
tive responses while at the high dose, they are mostly
involved in cell cycle processes.
Comparison with Voy et al. analysis
A report by Voy et. al has used a systems biology ap-
proach for the analysis of the effects of low dose ionising
(10 cGy) radiation in mice spleen [40]. Voy et. al identify
sets of co-expressed genes by identifying ‘cliques’ in co-
expression networks.
Voy and colleagues harvested their tissue at 3.5 h and
exposed the tissue to 10 cGy ionising radiation. We
compared our microarray results obtained at 3 h to
theirs. Despite the difference in the kind of tissue and
model between the two studies, we found many similar-
ities in the biological processes. In our study we noted
that immune response was the predominant response at
dose 10 cGy at 3 h. Voy et. al also concluded that im-
mune response pathways were highly activated at dose
10 cGy at 3.5 h. Furthermore, some genes like Notch, IL,
Cyp, Stat, Tmem, etc. were found in both studies. We
also found several transmembrane (Tmem-) genes which
were also identified in their study and hypothesised to
Figure 8 Significant biological processes of genes with large connectivity differences between netCD1 and netCD2 at 3 h. Significant
processes from GeneGo of the genes with high difference (≥ 10 connections) in connectivity between networks netCD1 and netCD2. The
number in parentheses is the number of genes having a higher connectivity in that network. The FDR of the biological processes of the 55 genes
having a greater number of connections in dose0-10 cGy network is 0.05 and that of the 59 genes with greater connections in dose0-100 cGy
network is 0.1.
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ours and that of Voy et. al are complimentary, as well as
help in providing support for the results obtained using
sophisticated computational methods such as ours in
studies relating to LDIR.
Connectivity difference of genes between the common
DE genes network and all DE genes network
Networks networkA, networkB, networkC, networkD,
networkE, networkF, networkG and networkH were built
from all the DE genes obtained by comparing the gene
expression between either dose 10 cGy or 100 cGy with
control dose 0 cGy at different time points (see Table 1).
In this section, we analyse the connectivity of the com-
mon DE genes (Table 1, lower half ) within the networks
built with all the DE genes (Table 1, upper half ). This
idea is illustrated in Figure 6 - Analysis II. For example,
the connectivity of 503 genes that are common to the
sets of DE genes obtained by comparing dose 0 cGy with
dose 10 cGy and dose 0 cGy with dose 100 cGy will be
investigated in networks networkC, networkD, netCD1
and netCD2. Genes with a difference in the number ofconnections/links/edges ≥T, where T is some threshold,
are analysed further for biological relevance. For this
study, we chose T= 10.
Among the 503 common DE genes (between netCD1
and netCD2), 105 genes had a connectivity difference
≥10 between networkC and networkD, whereas 29 genes
had a connectivity difference ≥10 between networkC
and networkD, and between netCD1 and netCD2. The
set of 29 genes included genes like Cyclin G2 (CCNG2),
CAMP responsive element binding protein 3-LIKE 2
(CREB3L2), eukaryotic translation initiation factor 3,
subunit D (eIF3d), forkhead box O1 (FOXO1A), mye-
loid/lymphoid or mixed-lineage leukemia (MLLT11),
protein phosphatase 2, regulatory subunit B, gamma iso-
form (PPP2R2C). Among the 105 genes were genes
linked to breast cancer, such as retinoblastoma 1, cyclin-
dependent kinase inhibitor 1a, etc. This set also included
genes like cyclin-dependent kinase inhibitor 1A
(CDKN1A), FYN oncogene related to SRC, FGR, YES
(FYN), G protein-coupled receptor, family C, group 5,
member A (GPRC5A), mastermind-like 1 (MAML1),
MAX dimerisation protein 1 (MXD1), membrane
Figure 9 Significant biological processes of genes with large connectivity differences between netEF1 and netEF2 at 8 h. Significant
processes from GeneGo of the genes with high difference (≥ 10 connections) in connectivity between networks netEF1 and netEF2. The number
in parentheses is the number of genes having a higher connectivity in that network. The FDR of the biological processes of the 16 genes having
a greater number of connections in dose0-10 cGy network is 0.05 and that of the 22 genes with greater connections in dose0-100 cGy network is
0.05.
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(TCF20), tumor protein p53 inducible nuclear protein 1
(TP53INP1), etc. The significant biological processes of
the 105 genes (See Additional file 8) is shown in
Figure 12.
Of the 86 common DE genes (between netEF1 and
EF2), 10 genes had a connectivity difference ≥10 be-
tween networkE and networkF, and between netEF1 and
netEF2, whereas there were 28 genes with a connectivity
difference ≥10 only between networkE and networkF
networks (See Additional file 9). Furthermore, the breast
cancer 1, early onset (BRCA1) gene was one of the 10
genes. Numerous studies have BRCA1 is crucial for
maintaining genomic stability, DNA repair and is a
tumour suppressor [41,42]. It had greater number of
connections in the dose 0–10 cGy network (networkE).Cyclin-dependent kinase inhibitor 1A (CDKN1A),
homeobox D13 (HOXD13), interferon regulatory factor
2 binding protein 2 (IRF2BP2), ribonucleotide reductase
M2 (RRM2), UDP-N-acetyl-alpha-D-galactosamine poly-
peptide N-acetylgalactosaminyltransferase 3 (GALNT3),
etc. were among the 28 genes. The set of 28 genes was
too small to identify statistically significant processes,
however, the genes were mainly involved in metabolism
and Pol II transcription.
99 genes out of the 482 common DE genes had a con-
nectivity difference≥ 10 between networkG and networkH
(See Additional file 8). Aurora kinase A (AURKA), centro-
mere protein A (CENPA), CHK1 checkpoint homolog
(CHEK1), chromodomain helicase DNA binding protein
1-like (CHD1L), SCL/TAL1 interrupting locus (STIL), etc.
were among the genes present in the set of the 99 genes.
Figure 10 Significant biological processes of genes with large connectivity differences between netGH1 and netGH2 at 24 h. Significant
processes from GeneGo of the genes with high difference (≥ 10 connections) in connectivity between networks netGH1 and netGH2. The
number in parentheses is the number of genes having a higher connectivity in that network. The FDR of the biological processes of the 55 genes
having a greater number of connections in dose0-10 cGy network is 0.05 and that of the 67 genes with greater connections in dose0-100 cGy
network is 0.05.
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of the cell cycle. The significant biological processes of the
99 genes (See Additional file 10) is shown in Figure 13.
Conclusions
Ionising radiation is a proven human carcinogen. Most
studies have analysed the effects of high dose radiation
such as atomic bomb survivors in Japan, people exposed
during the Chernobyl nuclear accident, patients under-
going radiation therapy, uranium miners, etc. However,
it has been difficult to measure and assess the risk of
cancer in people exposed to lower doses of ionising radi-
ation such as the people living at high altitudes, who are
exposed to more natural background radiation from cos-
mic rays than people at sea level. In our study, one ofFigure 11 Statistically significant biological processes across time and
dominant at each time and dose.the points of interest was that as time progressed and
even though the biological processes were very different
across doses at 3 h, the response - by the set of common
DE genes- to both 10 cGy (low) and 100 cGy (high)
doses of X-ray radiation was similar in terms of the bio-
logical pathways (mostly cell cycle processes) affected at
24 h (Figure 11). Most of the processes at 24 h under
both doses are associated with mitosis checkpoints. We
have shown that the set of common DE genes account
for a large percentage of the DE genes at each compari-
son. Therefore we claim that even 10 cGy radiation is
not ‘low’ when analysed from a biological processes
viewpoint. It is possible that cells exposed to the LDIR
have better survival compared to the cells exposed to
the HDIR after 24 h, despite the similarity in thedose. Topological analysis showed what processes were more
Figure 12 Significant biological processes of genes with large connectivity differences between networkC and networkD at 3 h.
Significant processes (FDR= 0.05) of the 105 genes that had≥ 10 network connections difference between networks networkC and networkD.
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idea. It must be noted that our results may be specific to
the model used in our study, but comparison to other
LDIR studies have shown similar results in terms of the
biological processes at each time and dose [29,30,43].
In this analysis we applied systems biology network
analysis methods to study the difference in the effects of
two doses of radiation on skin cells at different time
points. This computational method of analysis helps to
identify transcriptional differences between two very
similar conditions. Our method of analysis is a way of
fine tuning down to the sets of genes that may be key
players at a certain time and, hence, by investigating the
biological pathways of those key genes, we were able to
identify the dominating processes at each time point. SoFigure 13 Significant biological processes of genes with large connec
Significant processes (FDR= 0.05) of the 99 genes that had≥ 10 network coit is the difference between coarse tuning - using DE
gene selection or clustering and then identifying bio-
logical pathways technique - and fine tuning - our
method of analysis via topological analyses.
Eukaryotic cells have many biological mechanisms to
identify and repair damaged DNA to preserve genomic
integrity. These mechanisms include the activation
checkpoints and induction of cell cycle arrest, to allow
the cell time to repair the damage. Cell cycle arrest can
be triggered at G1/S, intra-S and G2/M phases. We saw
these processes being dominant at various dose and time
points in Figure 11. Microarray expression analysis of
skin cells under normal conditions would probably show
similar biological processes over time as cell cycle activ-
ity in skin cells is very high. There aren’t any reports oftivity differences between networkG and networkH at 24 h.
nnections difference between networks networkG and networkH.
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the best of our knowledge, to verify this idea. It is due to
topological analyses that we were able to extract genes
which have been reported to be highly associated with
cancer, such as BRCA1, ageing, immune response, etc.,
which would not have been present under normal condi-
tions. Methods like ours can help in generating testable
hypotheses while dealing with high throughput data.
There has been a report by Voy et. al that has used a
systems biology approach for analysing the effects of low
dose ionising (10 cGy) radiation [40]. Voy et. al identify
sets of co-expressed genes by identifying ‘cliques’ in co-
expression networks. To the best of our knowledge, Voy
et. al is the only group, other than ours, that has ana-
lysed LDIR from a networks perspective. Not only is our
experimental design very different but our computa-
tional analysis is also different. Our network topological
analyses seek to identify the differences between two ra-
diation doses networks, i.e. identify the differences
across very similar conditions. We consider 10 cGy and
100 cGy ‘similar’ in the sense that both are ionising radi-
ation and the conditions are similar although the magni-
tudes are different. Furthermore, we use only local
network properties to distinguish between the doses.
The reason for this is that global network characteristics
of very similar conditions (represented as networks) do
not have enough power to distinguish between condi-
tions. For example, consider two oranges - one sweet
and one sour. Both look the same in terms of structure
and texture, however, they differ in taste. If we built a
network to represent the sweet orange and the sour or-
ange, the global network characteristics, such as network
density, mean network connectivity, etc. would be simi-
lar between the two orange networks. However, since
there is a difference in taste, there will be some differ-
ences between these two networks which would be local
network properties. Therefore, we do not use global
properties to identify the differences between dose
10 cGy and 100 cGy in this manuscript. Other reports
have also shown how global properties cannot distin-
guish between very similar networks [7,44].
Systems biology methods like ours are in high demand
as the differences between many conditions, be they
neurodegenerative diseases, brain diseases, different
kinds of cancers, different degrees of disease severity,
etc., are very subtle and cannot be easily highlighted
using the usual off-the-shelf clustering or biological
pathways identification algorithms. Comparing networks
of any kind - social, biological, etc. - is a difficult and on-
going field of research. Comparisons of gene coexpres-
sion networks by identifying hub genes or by looking at
the neighbourhoods of gene in networks that share few
common genes and have many different genes between
them (both are cases where there are very obviousdifferences between networks that can be detected using
simple methods), has been previously reported. However,
comparing different networks representing very similar
conditions and trying to identify the differences between
them is a difficult task. We have presented the applica-
tion of a method that can aid in this task.
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